Anti-GP6/Glycoprotein-6 Antibody (Glenzocimab)
Catalog No.
F1702
Anti-GP6/Glycoprotein-6 Antibody (Glenzocimab)
Featured Products
Glenzocimab (ACT017) is a Fab fragment of a humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential to be used in the study of acute ischemic stroke.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
48.29 kDa
Dry ice
2101829-58-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ACT017, 9O12.2
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9HCN6
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
GP6 / Glycoprotein-6
Please avoid freeze-thaw cycles.